TheraPsil
TheraPsil is a Canadian non-profit founded in 2019 that trains healthcare professionals in psychedelic-assisted therapy, supports patients seeking legal psilocybin access, runs the PsilWell clinical trial, and advocates for psychedelic regulatory reform in Canada.
- Company typePrivate
- Founded2019
- HeadquartersVictoria, Canada
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What TheraPsil does
TheraPsil is a Canadian non-profit founded in 2019 on Vancouver Island, headquartered in Victoria, British Columbia. The organization trains healthcare professionals in psychedelic-assisted psychotherapy and operates patient-support and advocacy programs aimed at expanding legal access to psilocybin in Canada. Its product set is curriculum-based rather than software-based: Psilocybin-Assisted Therapy Training, MDMA-Assisted Therapy Training, Prescriber Courses for psilocybin and MDMA, Psychedelic First Aid and Advanced Seminars, On-Demand self-paced modules, and a supervised Experiential Psilocybin Training component. Adjacent offerings include patient navigation services (therapist and co-sitter directories), the PsilWell Clinical Trial for psilocybin outcomes research, recurring masterclass events with leading researchers, grassroots legal advocacy (including support for Thomas' Bill), and a merchandise storefront. The organization's underlying technology consists of online training portals, a membership platform, and clinical trial management infrastructure — there is no proprietary AI, software-as-a-service product, or app.
TheraPsil firmographics
Firmographics- Name
- TheraPsil
- Legal name
- TheraPsil
- Website
- https://therapsil.ca
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- TheraPsil is a Canadian non-profit founded in 2019 that trains healthcare professionals in psychedelic-assisted therapy, supports patients seeking legal psilocybin access, runs the PsilWell clinical trial, and advocates for psychedelic regulatory reform in Canada.
- Ownership category
- akta.pro rank
TheraPsil industry classification
Industry- Product category
- Psychedelic-Assisted Therapy Training
- NAICS
- Educational Support Services (61171), Outpatient Mental Health and Substance Abuse Centers (621420), Other Individual and Family Services (624190)
- SIC
- Services-Educational Services (8200), Services-Social Services (8300)
- akta.pro primary industry
- Behavioral Health & Counseling (Social Work, Psychology, Substance Use CE) (EDAAALAD)
- akta.pro secondary industry
- Peer Support, Recovery Coaching & Sober Living Services (HLAFACAN)
Keywords
Where TheraPsil is headquartered
LocationHeadquarters
- HQ city
- Victoria
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
TheraPsil business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Training Program Fees: Revenue from psychedelic therapy training programs for healthcare professionals including Psilocybin-Assisted Therapy, MDMA-Assisted Therapy, and Prescriber courses offered in-person and online.
- Membership Fees: Monthly or annual membership subscriptions providing access to newsletters, webinars, bonus training resources, hub directories, exclusive events, and advocacy access.
- Merchandise Sales: Sale of branded merchandise including the 'Right to Try Organic Cotton Tote' at $26 per unit.
- Donations and Advocacy Support: Donations funding legal advocacy, public education, and direct patient support for expanding compassionate psilocybin access in Canada.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Masterclass General Admission |
| One time/ perpetual license | Pay-as-you-go | Masterclass Member Rate |
| Unit Pricing | Pay-as-you-go | Right to Try Organic Cotton Tote |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
TheraPsil product offering
Product offeringCore offering
TheraPsil delivers professional training programs in psychedelic-assisted psychotherapy (psilocybin and MDMA) to healthcare professionals, delivered in small supervised cohorts in-person in Victoria/Toronto and online. It also provides patient support and navigation services connecting patients with trained therapists, operates the PsilWell clinical trial, maintains therapist and co-sitter directories, runs a subscription membership program, hosts masterclass events, and conducts grassroots advocacy for legal psilocybin access in Canada.
Product overview
TheraPsil is a non-profit training and advocacy organization (not a technology product company) offering psychedelic-assisted therapy education programs for healthcare professionals. The core offering consists of multiple training programs including Psilocybin-Assisted Therapy Training, MDMA-Assisted Therapy Training, Prescriber Courses, and Experiential Training components. Additional services include patient support programs (therapist and co-sitter directories), the PsilWell clinical trial research program, advocacy efforts for legal access, membership benefits, educational masterclass events, and merchandise. The organization does not offer a software platform, SaaS product, or technology solution.
Differentiator
Problem solved
Functional benefit
Products and services
- Psilocybin-Assisted Therapy Training Comprehensive training program for healthcare professionals covering psilocybin-assisted psychotherapy techniques, including fundamentals, in-person and online formats, and supervision components leading to supervised experiential training.
- MDMA-Assisted Therapy Training Training program for healthcare professionals on MDMA-assisted psychotherapy protocols and clinical practices.
- Prescriber Courses (Psilocybin & MDMA) Specialized courses for prescribing clinicians on protocols for psilocybin and MDMA therapies.
- Psychedelic First Aid & Advanced Seminars Advanced seminars covering psychedelic first aid and practitioner preparedness.
- Experiential Psilocybin Training Supervised hands-on experiential training allowing participants to experience psilocybin-assisted therapy under monitored conditions.
- PsilWell Clinical Trial Clinical trial program investigating psilocybin therapy outcomes in patient populations.
- Patient Support Services Services connecting qualified individuals to trained psychedelic therapy providers, including application support for legal access.
- Masterclass Events Educational full-day masterclasses featuring leading voices in psychedelic research, with featured speakers and panel discussions.
- Advocacy & Legal Access Program Grassroots advocacy efforts for psychedelic regulations, legal challenges, and patient access to psilocybin therapy in Canada.
- Membership Program Recurring monthly or annual membership providing access to newsletters, webinars, training portals, directories, exclusive events, and community connections.
- Therapist Directory Directory of trained psychedelic therapy practitioners available for patient referrals.
- Co-Sitter Directory Directory of trained co-sitters for psychedelic-assisted therapy sessions.
- Right to Try Organic Cotton Tote Branded organic cotton tote bag featuring 'Right to Try' messaging to support psychedelic advocacy. Priced at $26 per unit.
Quantifiable outcome
- 80% of participants experience significant relief from depression and anxiety after psilocybin therapy in clinical trials
Companies that use TheraPsil
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
TheraPsil technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
TheraPsil partnerships and signals
Strategic signalPartnerships
25 partnerships are on record, tiered minor.
- ACER IntegrationminorListed as part of TheraPsil's broader psychedelic ecosystem. Organizations in the ecosystem help shape the future of psychedelic care alongside TheraPsil.
- Apex LabsminorListed as part of TheraPsil's broader psychedelic ecosystem.
- BlossomminorListed as part of TheraPsil's broader psychedelic ecosystem.
- ChacrunaminorListed as part of TheraPsil's broader psychedelic ecosystem.
- ClusterbustersminorListed as part of TheraPsil's broader psychedelic ecosystem.
- CRIOminorListed as part of TheraPsil's broader psychedelic ecosystem.
- Dr. Bronner'sminorListed as part of TheraPsil's broader psychedelic ecosystem.
- Drug ScienceminorListed as part of TheraPsil's broader psychedelic ecosystem.
- Enhanced Therapy InstituteminorListed as part of TheraPsil's broader psychedelic ecosystem.
- Filament HealthminorListed as part of TheraPsil's broader psychedelic ecosystem.
- First SessionminorListed as part of TheraPsil's broader psychedelic ecosystem.
- Global Psychedelics WeekminorListed as part of TheraPsil's broader psychedelic ecosystem.
- Heroic Hearts CanadaminorListed as part of TheraPsil's broader psychedelic ecosystem.
- MAPS CanadaminorListed as part of TheraPsil's broader psychedelic ecosystem.
- NikeanminorListed as part of TheraPsil's broader psychedelic ecosystem.
- OPISminorListed as part of TheraPsil's broader psychedelic ecosystem.
- Optimi HealthminorListed as part of TheraPsil's broader psychedelic ecosystem.
- Psychedelic Association of CanadaminorListed as part of TheraPsil's broader psychedelic ecosystem.
- Psychedelics & Pain AssociationminorListed as part of TheraPsil's broader psychedelic ecosystem.
- PsygenminorListed as part of TheraPsil's broader psychedelic ecosystem.
- PsyGaiaminorListed as part of TheraPsil's broader psychedelic ecosystem.
- Psychedelic Training NZminorListed as part of TheraPsil's broader psychedelic ecosystem.
- Psilocybin San FranciscominorListed as part of TheraPsil's broader psychedelic ecosystem.
- REMAP TherapeuticsminorListed as part of TheraPsil's broader psychedelic ecosystem.
- SABI MindminorListed as part of TheraPsil's broader psychedelic ecosystem.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
TheraPsil competitors and assessment
Company assessmentDirect peers
- Fluence: Provides psychedelic-assisted therapy training programs for clinicians, including ketamine and psilocybin tracks. Closely comparable to TheraPsil's training portfolio, curriculum structure, and target customer base of healthcare professionals.
- Naropa University Psychedelic Training Program: Offers continuing-education psychedelic-assisted therapy training for licensed clinicians. Closely comparable product offering and target audience to TheraPsil's professional training programs.
- Psychedelic Association of Canada: Canadian national organization advancing psychedelic therapy and policy reform. Directly comparable advocacy mission to TheraPsil, listed as an ecosystem ally with overlapping member base.
- MAPS Canada: Canadian arm of the Multidisciplinary Association for Psychedelic Studies, focused on MDMA-assisted therapy training, research, and policy advocacy. Directly comparable to TheraPsil as a Canadian psychedelic healthcare training and advocacy organization.
Broad incumbents
- Compass Pathways: Publicly listed clinical-stage psychedelic therapy company running psilocybin trials and developing proprietary COMP360 protocols. Larger, capital-backed player with overlapping patient, clinician, and policy ecosystem compared to TheraPsil.
- Multidisciplinary Association for Psychedelic Studies (MAPS): Foundational psychedelic research and training organization sponsoring MDMA-assisted therapy protocols globally. Operates broader portfolio (clinical trials, public policy, training) but competes directly with TheraPsil on therapist training and patient access advocacy.
- California Institute of Integral Studies (CIIS) Center for Psychedelic Therapies and Research: University-based program offering certificate-level psychedelic therapy training for clinicians. Comparable to TheraPsil's training mission, with greater institutional backing but U.S. focus rather than Canadian.
Emerging players
- SABI Mind: Canadian psychedelic-assisted therapy clinic network with therapist directories and patient services. Comparable to TheraPsil's patient-support and therapist-directory offering, with overlap in clinician community and listed ecosystem partnership.
Others
- Filament Health: Canadian natural psychedelic drug development company and listed TheraPsil ecosystem partner. Adjacent as a drug-development supplier rather than training peer, but provides supply chain context for TheraPsil's clinical work.
Regional players
- Psychedelic Training NZ: New Zealand-based psychedelic therapy training organization listed as part of TheraPsil's ecosystem. Directly comparable in training mission, with primary geographic focus on Aotearoa New Zealand where TheraPsil is also expanding.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
TheraPsil social profiles
Digital presenceTheraPsil financial estimates
Financial estimateRevenue estimate
Valuation estimate
TheraPsil leadership team
Management profileNumber of profiles
Profiles6 records
TheraPsil funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TheraPsil M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TheraPsil
What does TheraPsil do?
TheraPsil delivers professional training programs in psychedelic-assisted psychotherapy (psilocybin and MDMA) to healthcare professionals, delivered in small supervised cohorts in-person in Victoria/Toronto and online. It also provides patient support and navigation services connecting patients with trained therapists, operates the PsilWell clinical trial, maintains therapist and co-sitter directories, runs a subscription membership program, hosts masterclass events, and conducts grassroots advocacy for legal psilocybin access in Canada.
Is TheraPsil a public or private company?
TheraPsil is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was TheraPsil founded?
TheraPsil was founded in 2019. It employs 11 to 50 people.
Where is TheraPsil based?
TheraPsil is headquartered in Victoria, Canada, in the North America region.
How does TheraPsil make money?
Four revenue lines are on record. Training Program Fees are the primary driver. The others are membership Fees, merchandise Sales and donations and Advocacy Support.
Who are TheraPsil's main competitors?
Direct peers on record are Fluence, Naropa University Psychedelic Training Program, Psychedelic Association of Canada and MAPS Canada. Broad incumbents are Compass Pathways, Multidisciplinary Association for Psychedelic Studies (MAPS) and California Institute of Integral Studies (CIIS) Center for Psychedelic Therapies and Research. SABI Mind is listed as an emerging player. Filament Health is listed as an others. Psychedelic Training NZ is listed as a regional player.
Does TheraPsil have an API?
No public API is recorded for TheraPsil.
What industry is TheraPsil in?
TheraPsil's product category is Psychedelic-Assisted Therapy Training. Its primary akta.pro industry code is EDAAALAD, Behavioral Health & Counseling (Social Work, Psychology, Substance Use CE), with a secondary code of HLAFACAN, Peer Support, Recovery Coaching & Sober Living Services. Its NAICS code is 61171 and its SIC code is 8200.